@article{JTD8541,
author = {Seokkee Lee and Hyo Chae Paik and Seok Jin Haam and Chang Young Lee and Kyung Sik Nam and Hee Suk Jung and Young Woo Do and Jee Won Shu and Jin Gu Lee},
title = {Sarcopenia of thoracic muscle mass is not a risk factor for survival in lung transplant recipients},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {8},
year = {2016},
keywords = {},
abstract = {Background: In lung transplantation (LTx), patients with thoracic muscle sarcopenia may have to require longer to recovery. We measured thoracic muscle volume by using the cross sectional area (CSA) and assessed its effect on early outcomes after LTx.
Methods: A retrospective analysis was conducted to evaluate the effect of thoracic sarcopenia in patients undergoing LTx between January 2010 and July 2015. The lowest CSA quartile (Q1) was defined as sarcopenia.
Results: In total, 109 patients were enrolled. The mean CSA was 58.24±15.82 cm2. Patients in the highest CSA quartile were more likely to be male (92.6% vs. 17.9%, P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/8541}
}